Covid-19 patients rush to join studies of remdesivir drug

  1. home
  2. > health
  3. > Covid-19 patients rush to join studies of remdesivir drug
replay trump newslist
up NEXT IN 5 SECONDS sports newslist
tap to unmute
00:00/00:00
NaN/0

Covid-19 patients rush to join studies of remdesivir drug

Apr 06, 2020 18:54 IST

Coronavirus patients around the world have been rushing to join remdesivir studies that opened in hospitals in the last few weeks. Interest has been so great that the U.S. National Institutes of Health is expanding its study, which has nearly reached its initial goal of 440 patients. The drug's maker, California-based Gilead Sciences, is quickly ramping up its own studies, too.

Health